These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37544334)

  • 1. Interpreting permeability as a function of free drug fraction: The case studies of cyclodextrins and liposomes.
    Tzanova MM; Nguyen L; Moretti F; Grassi M; Magnano GC; Voinovich D; Stein PC; Hiorth M; di Cagno MP
    Eur J Pharm Sci; 2023 Oct; 189():106559. PubMed ID: 37544334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
    Sridevi S; Diwan PV
    Eur J Pharm Biopharm; 2002 Sep; 54(2):151-4. PubMed ID: 12191685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability.
    Eriksen JB; Christensen SB; Bauer-Brandl A; Brandl M
    J Pharm Sci; 2022 Jun; 111(6):1667-1673. PubMed ID: 34808218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in Solubility-Permeability Interplay of Psoralens from
    Machado RD; Silva JCG; Silva LAD; Oliveira GAR; Lião LM; Lima EM; de Morais MC; da Conceição EC; Rezende KR
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Solubility-Permeability Trade-Off of Progesterone With Cyclodextrins Under Physiological Conditions: Experimental Observations and Computer Simulations.
    Sun L; Zhang B; Sun J
    J Pharm Sci; 2018 Jan; 107(1):488-494. PubMed ID: 29031956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.
    Hatzi P; Mourtas S; Klepetsanis PG; Antimisiaris SG
    Int J Pharm; 2007 Mar; 333(1-2):167-76. PubMed ID: 17101248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
    Bary AR; Tucker IG; Davies NM
    Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
    McCormack B; Gregoriadis G
    Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
    Joguparthi V; Anderson BD
    Pharm Res; 2008 Nov; 25(11):2505-15. PubMed ID: 18642063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin.
    Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI
    Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
    Felton LA; Wiley CJ; Godwin DA
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of tropicamide by hydroxypropyl-beta-cyclodextrin and water-soluble polymers: in vitro/in vivo studies.
    Cappello B; Carmignani C; Iervolino M; Immacolata La Rotonda M; Fabrizio Saettone M
    Int J Pharm; 2001 Feb; 213(1-2):75-81. PubMed ID: 11165095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of α-Pinene in Delivery Systems Based on Liposomes and Cyclodextrins.
    Hammoud Z; Kayouka M; Trifan A; Sieniawska E; Jemâa JMB; Elaissari A; Greige-Gerges H
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Characterization of Liposomes Double-loaded with Amphotericin B and Amphotericin B/hydroxypropyl-beta-cyclodextrin Inclusion Complex.
    Tran THY; Vu TTG; Pham TMH
    Pharm Nanotechnol; 2021; 9(3):236-244. PubMed ID: 33745428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-in vivo correlation in the effect of cyclodextrin on oral absorption of poorly soluble drugs.
    Aihara R; Messerschmid R; Mizoguchi M; Wada K; Minami K; Higashino H; Takagi T; Kataoka M; Yamashita S
    Int J Pharm; 2021 May; 600():120494. PubMed ID: 33744446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.